(R)-2-Methylbutanoic acid
Common Name: |
(R)-2-Methylbutanoic acid |
IUPAC Name: |
(2R)-2-methylbutanoic acid |
Molecular Formula: |
C5H10O2 |
SMILES: |
CCC(C)C(=O)O |
Inchi: |
1S/C5H10O2/c1-3-4(2)5(6)7/h4H,3H2,1-2H3,(H,6,7)/t4-/m1/s1 |
Inchi Key: |
WLAMNBDJUVNPJU-SCSAIBSYSA-N |
Cas No: |
32231-50-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
102.13 |
Mass (g/mol) |
102.068 |
Molar Refractivity |
27.92 |
Net Charge |
-1 |
HBD |
1 |
HBA |
2 |
Rt Bonds |
2 |
Rings |
|
TPSA |
37.30 |
Hetero Atoms |
2 |
Heavy Atoms |
7 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
???? |
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.80 |
LogP |
1.117 |
iLOGP |
1.31 |
XLOGP3 |
1.18 |
WLOGP |
1.12 |
MLOGP |
0.89 |
ESOL Log S |
-1.08 |
ESOL Solubility (mg/ml) |
8.41 |
ESOL Solubility (mol/l) |
0.082 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.56 |
Ali Solubility (mg/ml) |
2.82 |
Ali Solubility (mol/l) |
0.03 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-0.41 |
Silicos-IT Solubility (mg/ml) |
40.1 |
Silicos-IT Solubility (mol/l) |
0.39 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.09 |
Bioavailability Score |
0.85 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.469 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.625 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |